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ABSTRACT The protein caldesmon inhibits actin-activated ATP hydrolysis of myosin and inhibits the binding of myosin*ATP
to actin. Afragment isolated from a chymotryptic digest of caldesmon contains features of the intact molecule that make it useful
as a selective inhibitor of the binding of myosin ATP complexes to actin without having the complexity of binding to myosin. The
COOH-terminal 20 kDa region of caldesmon binds to actin with one-sixth the affinity of caldesmon with a stoichiometry of binding
of one fragment per two actin monomers. This contrasts with the 1:6-9 stoichiometry of intact caldesmon. The binding of the
20 kDa fragments to actin is totally reversed by Ca2+-calmodulin and, like intact caldesmon, the 20 kDa fragments are com-
petitive with the binding of myosin subfragments to actin. This competition with myosin binding is largely responsible for the
inhibition of ATP hydrolysis, although both the fragments and intact caldesmon also reverse the potentiation ofATPase activity
caused by tropomyosin. These polypeptides are useful both in defining the function of caldesmon and in studying the role of
weakly bound cross-bridges in muscle.
INTRODUCTION
Caldesmon is associated with actin filaments in smooth mus-
cle and nonmuscle cells and has been implicated in the reg-
ulation of motility (1-8). The inhibition of actin-activated
myosin ATPase activity by caldesmon appears to occur by a
mechanism different from that of the tropomyosin-troponin
complex of striated muscle. Studies in solution (9, 10) and
in single skeletal muscle fibers (6) have shown that
tropomyosin-troponin alters the rate of transition from non-
force-producing cross-bridge states (weak binding states) to
force producing states (strong binding states). In contrast, the
results of several studies indicate that caldesmon inhibits the
binding of myosin to actin. Thus, under conditions where
caldesmon does not bind to myosin, caldesmon inhibits both
the ATPase activity and binding to actin of skeletal myosin
subfragment 1 (S-1) (11) and smooth heavy meromyosin
(HMM) (12-14). Caldesmon has also been shown to com-
pete with the binding of various myosin subfragments to
actin in the presence of pyrophosphate (11) and adenyl-5'-yl
imidodiphosphate (AMP-PNP) (15-17) and in the absence of
nucleotide (18, 19). The binding of caldesmon to actin is
reversed by antibodies that reverse the binding of S-1 ATP
to actin (20). Furthermore, the inhibition of ATPase activity
by caldesmon occurs with a large change in the apparentKm
(13, 21).
We have shown that caldesmon may diffuse into single-
skinned striated muscle fibers with subsequent inhibition of
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binding ofweakly bound cross-bridges and the production of
force (6, 10). However, intact caldesmon has two properties
that detract from its usefulness as a probe of cross-bridge
function. First, the diffusion of caldesmon into single fibers
is slow, requiring more than an hour to obtain full equili-
bration. Second, caldesmon binds to myosin, as well as to
actin (15), and this could cross-link actin to myosin and com-
plicate the analysis of mechanical measurements of fibers.
These problems can be avoided by using smaller proteolytic
fragments of caldesmon that do not contain the myosin-
binding region.
We have found that the most useful of the inhibitory actin-
binding fragments originate at either Lys579 or Leu597 in the
primary structure of caldesmon and terminate at or near the
COOH terminus (19). These fragments diffuse rapidly into
fibers and inhibit the active force production of both skeletal
(6) and smooth (7) muscle fibers. We now report the details
of the interactions of these fragments that provide the basis
for their use as probes of weak cross-bridge binding. The
results presented here also help to define further the mech-
anism by which caldesmon inhibits actin-myosin interac-
tions.
EXPERIMENTAL PROCEDURES
Skeletal actin was isolated from rabbit back and leg muscles by the method
ofSpudich and Watt (22) as modified by Eisenberg and Kielley (23). Smooth
muscle tropomyosin was isolated from turkey gizzards (24). Calmodulin
was purified from porcine brains (25). Skeletal muscle myosin was isolated
from the back and leg muscles of rabbits (26), and chymotryptic S-1 was
prepared by the method of Weeds and Taylor (27). Caldesmon was isolated
from turkey gizzards by the method of Bretscher (24) as modified by Velaz
et al. (28). Chymotryptic fragments were prepared according to our pub-
lished procedure (19). The 20 kDa fragments used correspond to combined
peaks 1 through 3 of Fig. 2 of Chalovich et al. (19). In one experiment a
single 20 kDa fragment (equivalent to peak 2 of Fig. 2, Ref. 19) was used.
Protein concentrations were determined by absorbance at 280 nm except for
caldesmon, which was determined by the Lowry assay, using bovine serum
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albumin as a standard. The molecular weights used for calculation of protein
concentrations were 120,000 (S-1), 42,000 (actin), 68,000 (tropomyosin),
16,500 (calmodulin), and 87,000 (caldesmon). The average molecular
weight of the three actin-binding fragments of caldesmon was estimated to
be 20,000 (19).
Binding studies
Prior to binding, caldesmon or the 20 kDa fragments were reacted with a
twofold molar excess of ['4C]iodoacetamide in a buffer containing 100 mM
NaCl and 10 mM Tris-HCl (pH 8.0) for 5 h at 17°C. The extent of labeling
was about 0.4 mol of sulfhydryl groups modified per mole of caldesmon.
In the case of the 20 kDa fragments, only those polypeptides beginning with
Lys579 contain the radioactive label on Cys580. The binding of 14C-labeled
caldesmon to actin was determined by the centrifugation method described
previously (19, 28) under conditions given in the figure legends. Binding
data were corrected for (a) the fraction of caldesmon that did not form a
sediment even at saturating actin concentrations, (b) the amount of caldes-
mon that was present in the sediment in the absence of actin, and (c) the
fraction of actin (5%) that did not form a sediment (28). S-1 binding and
caldesmon binding to caldesmon were sometimes measured simultaneously.
In these cases, S-1 binding was measured using the NH4+/EDTA ATPase
assay as described by Chalovich and Eisenberg (29).
ATPase assays
The ATPase activity of myosin skeletal S-1 was measured by the liberation
of 32Pi from [32Pi]ATP as described earlier (29).
Affinity chromatography
Smooth muscle tropomyosin was cross-linked to CNBr-activated Sepharose
4B according to the manufacturer's protocol (Pharmacia LKB Biotechnol-
ogy, Inc.). The conditions of chromatography are described in the text.
Bound proteins were identified by electrophoresis using sodium dodecyl
sulfate (SDS) gels (30), with a 7-20% gradient of polyacrylamide, and
stained with Coomassie blue.
RESULTS
Several actin-binding fragments of caldesmon are formed
during the digestion of caldesmon with chymotrypsin. Four
closely related polypeptides of molecular weight of 18,000-
23,000 are easily separated from the caldesmon digest by
high-performance liquid cation exchange chromatography
(Fig. 2 of Ref. 19). These fragments, collectively called 20
kDa fragments, differ by several residues at either the NH2-
or COOH-terminal regions as shown in Fig. 1. While these
four fragments can be resolved by high-performance liquid
ion exchange chromatography, most experiments were per-
formed using this mixture of fragments, since we have found
no significant differences among these fragments. The bind-
ing of the 20 kDa fragments to actin was measured by cosed-
imentation of the 14C-labeled fragments with F-actin. Fig. 2
shows the results of binding to both pure actin (open sym-
bols) and to actin-tropomyosin (closed symbols). Each sym-
bol represents a different caldesmon fragment preparation
and a single binding experiment. The model of McGhee and
von Hippel (31) was fitted to the data to estimate the binding
constant K for the binding of a single fragment to an isolated
lattice site composed of n actin monomers and the cooper-
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FIGURE 1 Location of COOH-terminal polypeptide fragments of caldes-
mon. The region of caldesmon from residue 550 through the carboxyl ter-
minus, residue 756, is shown (see Ref. 43). The 20 kDa fragment is a mixture
of polypeptides differing slightly in the NH2- and COOH-terminal regions
(1, 0). The composition of these fragments is, typically: 42% fragment
Lys579 (22.9 kDa), 47% fragments Lys579 (20.1 kDa) + Leu597 (20.1 kDa),
and Leu597 (18.2 kDa) was 11% of the total mass (the fragments are de-
scribed by their NH2-terminal residue, and the apparent molecular weight
is given in parentheses). The 7.3 kDa (19) and 10 kDa (40) fragments,
derived from the 20 kDa fragments, contain a common region (U).
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FIGURE 2 Binding of the 20 kDa 14C-labeled fragments of caldesmon
to actin. Binding is shown in the absence (A, OL, 0) and in the presence
(AU, 0*) of smooth muscle tropomyosin in a solution containing 10 ,uM
skeletal muscle actin, 3.5 ,uM smooth muscle tropomyosin, 0.3 ,uAM skeletal
muscle myosin S-1, 2 mM ATP, 42 mM NaCl, 4.8 mM MgCl2, 0.25 mM
EGTA, 0.5 mM dithiothreitol, and 9.6mM imidazole (pH 7.2). Each symbol
represents a single binding experiment with different protein preparations.
The theoretical curve was fitted by usingK = 0.63 X 106 M-1,w = 1, and
n = 1.7. For the best fit of binding parameters to each data set see Table
1.
ativity parameter w, which is involved in the binding of tan-
dem caldesmon molecules (28).
Table 1 summarizes the data for the binding of the COOH-
terminal actin-binding fragment of caldesmon to actin in the
presence and absence of smooth muscle tropomyosin. The
value of n ranges from 1.7 to 2.6 (with an average of all
experiments of 2.0) mol actin/mol of the caldesmon frag-
ment. The value of X is between 1 and 2. The binding con-
stant K varies from 0.2 to 0.7 X 106 M-1. The lack of effect
of tropomyosin on the binding was not due to incomplete
saturation of actin with tropomyosin since similar results
were obtained at 0, 2.5, 3.5, and 6.0 ,uM tropomyosin. Fur-
thermore, for comparison, an experiment has been included
showing that tropomyosin increases the affinity of native
caldesmon to actin from 0.9 to 1.9 X 106 M-1. In this case,
50CYS
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TABLE 1 Analysis of the binding of the COOH-terminal,
20 kDa fragments of caldesmon to actin
Tropomyosin (,kM) co n K1 (X 10-6 M-1) No.*
0t 1.0 1.7 0.66 11
0 2.0 2.0 0.20 8
1.8 2.5 0.61 14
1.8 2.0 0.68 7
2.0 1.7 0.40 6
1.7 2.1 0.63 16
2.0 2.0 0.35 18
1.0 2.6 0.55 11
1.0 1.7 0.66 11
0§ 5.0 6.0 0.90 7
2.5t 1.0 1.7 0.66 9
3.5 2.0 2.0 0.20 10
1.8 2.5 0.61 7
1.8 2.0 0.68 7
1.7 2.1 0.63 12
2.0 2.0 0.35 8
1.0 2.0 0.55 9
1.0 1.7 0.66 9
6.0 1.0 2.5 0.55 9
2.5§ 5.0 6.0 1.94 6
* Number of experimental points.
i This experiment contained 7 ,uM actin, and different free concentrations
(0.1-10 ,uM) of the 20 kDa fragments of caldesmon. All other experiments
contained 10 ,iM actin.
§ Intact caldesmon, 7.0 ,uM actin.
the binding of native caldesmon to actin is 2.1 times tighter
in the presence of tropomyosin as compared with the 2.7-fold
increase reported earlier (28).
Caldesmon is known to bind directly to tropomyosin (32),
and it is often assumed that this direct interaction results in
the enhanced binding of caldesmon to actin in the presence
of tropomyosin. However, while there is little effect of tro-
pomyosin on the binding of the 20 kDa fragments to actin,
the 20 kDa fragments do bind to tropomyosin. Fig. 3 is an
SDS polyacrylamide gel showing the chromatographic pro-
file of digested caldesmon applied to a tropomyosin-
Sepharose affinity column. The polypeptides bound include
undigested caldesmon, a fragment of apparent molecular
weight 71,000, the large Mr 35,000-40,000 actin-binding
fragment, the myosin-binding fragment (apparent molecular
weight about 28,000), and the three small actin-binding
polypeptides (Mr 22,000, 20,000, and 18,000). Thus,
polypeptides from both the NH2- and COOH-terminal re-
gions of caldesmon appear to bind to tropomyosin. In a sep-
arate experiment, purified 14C-labeled Mr 20,000 fragments
were found to bind to the same column and elute in a NaCl
gradient between 0.14 and 0.16 M (not shown).
Fig. 4 shows the rate of ATP hydrolysis as a function of
the amount of the caldesmon 20 kDa polypeptides bound to
actin (open circles) and to actin-tropomyosin (closed circles).
In the absence of tropomyosin, the rate of ATP hydrolysis
decreases from 1.0 to 0.15 s-1 in nearly a linear fashion.
However, maximal inhibition ofATPase activity actually oc-
curs at less than stoichiometric binding of fragments to actin.
In this experiment, maximum binding occurred with a sto-
ichiometry of 1 fragment to 2-2.5 actin monomers, while
maximum inhibition occurred at about a 1:3 stoichiometry.
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FIGURE 3 SDS gel of the elution profile of chymotryptically cleaved
caldesmon on a smooth muscle tropomyosin-Sepharose affinity column.
The arrows indicate the position of standards (not shown): caldesmon (M,
120,000 on SDS gels), actin (Mr 42,000), and soybean trypsin inhibitor (Mr
21,500). (Lane 1) Digested caldesmon applied to the column in a buffer
containing 30 mM NaCl, 3 mM MgCl2, 0.5 mM EGTA, and 7 mM
imidazole-HCl (pH 7.2). (Lane 2) Caldesmon fragments not retained by the
column. (Lanes 3 and 4) Fractions eluted at 0.16 and 0.2 M NaCl, respec-
tively.
Although tropomyosin does not alter the binding of the 20
kDa fragments of caldesmon to actin, it does substantially
enhance the degree of inhibition of actin-activated ATP hy-
drolysis. In the presence of tropomyosin, the deviation be-
tween full saturation of actin with the 20 kDa fragments and
total inhibition of ATPase activity is large, as with intact
caldesmon (33, 28), with maximum inhibition occurring at
about 50% saturation. This could occur if tropomyosin made
caldesmon more effective in displacing bound S-1 or if there
were additional reductions in the kcat. Tropomyosin, by itself,
increases the actin activated ATPase activity of S-1 by about
twofold under the conditions of this experiment, and the 20
kDa fragments apparently reverse this potentiating effect. A
similar limiting ATPase rate is obtained in both the presence
and absence of tropomyosin, which is 0.15 s-1 in excess of
the rate of S-1 in the absence of actin. This feature was also
observed with intact caldesmon (33, 28). The inset to Fig. 4
shows the ATPase rates expressed relative to the rates in the
absence of caldesmon to show the difference in caldesmon
sensitivity caused by tropomyosin.
We had reported previously that intact caldesmon func-
tions largely by competitively inhibiting the binding of
S-1 ATP to actin (11, 14,15,18,28). Fig. 5 shows normalized
values of the ATPase rate and S-1 ATP bound to actin as a
function of the amount of the caldesmon fragment bound to
actin. In this experiment, only a single 20 kDa fragment was
used, which is the 20.1 kDa fragment (equivalent to peak 2
of Fig. 2, Ref. 19). Furthermore, the Al isozyme of myosin
S-1 was used, and the measurements were made at low ionic
strength to increase the accuracy of measurement of S-1
binding. The inhibition ofATPase activity, shown here in the
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FIGURE 4 Correlation between binding of the 20 kDa peptides of caldes-
mon to actin and inhibition of ATPase activity. The actin-activated myosin
skeletal S-1 ATPase rate and the binding of [14C]caldesmon peptides to actin
were measured simultaneously in mixtures containing 10 ,uM actin, 0.3 ,uM
S-1, variable caldesmon fragments concentrations, and either 0 ,JM (0, A,
R), 3.5 ,uM (A) or 6.0 ,uM (0) smooth muscle tropomyosin. The other
components of the solution were identical to those in Fig. 2. In the absence
of caldesmon, the ATPase rates were 1.8 and 1.0 s-1, in the presence and
absence of tropomyosin, respectively. The limiting ATPase rates at very high
caldesmon concentrations were 0.12 and 0.15 s-1, respectively, in the pres-
ence and absence of tropomyosin. (Inset)A replot of the same data in which
the ATPase rates, relative to the maximum value in each series, is shown as
a function of the fraction actin containing bound caldesmon fragment.
absence of tropomyosin, closely parallels the inhibition of
binding of S-1 ATP to actin. The ATPase rate data, for the
single 20.1 kDa fragment, closely resemble those from the
mixture of 20 kDa fragments shown in Fig. 4. This is further
justification of the use of a mixture of these closely related
polypeptides.
The 20 kDa fragments of caldesmon, like intact caldes-
mon, compete with the equilibrium binding of myosin S-1 to
actin in non-ATP-bound states. Fig. 6 demonstrates the com-
petition between S-1-AMP-PNP (a strong binding state) and
20 kDa caldesmon fragments for binding to actin. In this
experiment, the total caldesmon concentration was constant
while increasing amounts of S-1 *AMP-PNP were added. The
fraction of actin containing bound caldesmon fragments
(Theta II) decreased as the fraction of actin containing bound
S-1 AMP-PNP (Theta I) increased. Stoichiometric binding
of the strong binding S-1 AMP-PNP totally displaced the
caldesmon fragments from actin. This shows that the 20 kDa
fragments, like intact caldesmon, are mutually exclusive with
S-1 binding to actin. Both the pure competitive model
(dashed line) and the mosaic multiple-binding model (solid
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FIGURE 5 ATPase activity and (Al)S-1-ATP binding to actin as a func-
tion of the amount of 20.1 kDa caldesmon fragment bound to actin. The pure
20.1 kDa fragment of caldesmon (Ref. 19, Fig. 2, peak 2) was used rather
than the mixture of 20 kDa fragments. Both ATPase activity (0) and
S-1 -ATP binding (L) were measured at 25°C in solutions containing 1 mM
ATP, 3 mM MgCl2, 11 mM imidazole (pH 7.0), 0.1 ,uM (Al)S-1, and 10
,LM actin. In the absence of the caldesmon fragment 84% of the (Al)S-1
was bound and the ATPase activity was 8.8 s-1.
line) of binding were fit to these data (see Ref. 17). The two
models give similar fits at small values of n as in the present
case.
Fig. 7 shows that Ca2+-calmodulin displaces bound 20
kDa fragments from actin in a manner similar to that ob-
served earlier with intact caldesmon (11) and the 7.3 kDa
actin-binding fragment of caldesmon (19). Fifty percent in-
hibition of binding is achieved at a calmodulin concentration
of 25 and 12.5 ,uM for intact caldesmon (11) and the 20 kDa
fragments, respectively.
DISCUSSION
The 20 kDa fragments of caldesmon are similar to intact
caldesmon in their inhibition of acto-S-1 ATPase activity,
their response to tropomyosin in this inhibition, and their
competition with S-1 for binding to actin. Also of importance
is the observation that the effects of the 20 kDa fragments are
reversed by Ca2+-calmodulin since this provides a conve-
nient way of neutralizing the effects of these probes of cross-
bridge action. Two advantages of the 20 kDa fragments are
their more rapid diffusion into single muscle fibers (6) and
their lack of interaction with myosin (14). In contrast, intact
caldesmon binds to skeletal HMM and even to some extent
to skeletal S-1 at low ionic strength (15, 34). The simulta-
neous binding to myosin and actin can be misleading.
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FIGURE 6 Competition between the 20 kDa caldesmon fragments and
myosin skeletal S-1 for binding to actin. The conditions used were: 4 mM
AMP-PNP, 42 mM NaCl, 4.2 mM MgCl2, 0.25 mM EGTA, 10 mM imi-
dazole (pH 7.0), and 0.5 mM dithiothreitol with 10 ,uM actin, and 7.5 utM
14C-labeled caldesmon fragments. The skeletal S-1 concentration was varied
from 3.5 to 46.8 ,uM. Both the pure competitive (----) and mosaic multiple
( ) models were fit to these data. The association constants of both
S-1-AMP-PNP and the 20 kDa fragments to actin were 2 X 106 M-1, and
the cooperativity parameter, y, was 2. See Chen and Chalovich (17) for
details of the models.
The affinity of the 20 kDa fragments for actin (K X w =
8 X 105 M-1) is one-sixth of that for intact caldesmon (28)
and 18 times that of the 7.3 kDa fragment (19). The 20 kDa
fragments must contain the strongest actin binding site(s) of
the caldesmon molecule. The binding of the 20 kDa frag-
ments to actin is considerably stronger than the binding of
S-1 ATP to actin (K < 104 M`1 at 50 mM ionic strength).
This means that the 20 kDa fragments are good inhibitors of
the weak binding interaction. It is also important that the 20
kDa fragments bind less tightly than the strong binding cross-
bridges. For example, K > 2 X 106 M1 at 60 mM ionic
strength for HMM-AMP-PNP (35). The S-1 ADP complex
binds to actin with an even higher affinity (35). Thus the 20
kDa fragments are selective inhibitors of the population of
states known as weak binding states. This selectivity was
demonstrated in single rabbit psoas fibers, where it was
shown that caldesmon inhibits the attachment of cross-
bridges in the presence of ATP but not in the presence of
pyrophosphate (6).
A continuing question is whether caldesmon regulates AT-
Pase activity solely by blocking the binding of myosin'ATP
to actin or whether there is an additional component of reg-
ulation. The case for inhibition of myosin-ATP binding is
based on direct binding measurements in solution (11, 14-
16) on polarized fluorescence changes in ghost fibers (36)
and by the effect of caldesmon on the kinetics of ATP hy-
drolysis (13, 21, 37). Recent studies have also shown that
diffusion of caldesmon into rabbit psoas fibers results in a
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FIGURE 7 Reversal of binding of the 20 kDa, COOH-terminal caldes-
mon peptides to actin by Ca2+-calmodulin. Binding was measured at 25°C
in a solution containing 42 mM NaCl, 4.8 mM MgCl2, 10.5 mM imidazole
(pH 7.0), 0.25 mM EGTA, 0.5 mM dithiothreitol, 1.0 mM CaCl2, 10 ,uM
actin, and 8 ,uM 14C-labeled caldesmon fragments, and calmodulin was
varied from 5 to 80 ,LM.
reduction in stiffness measured in the presence of ATP, a
reduction in the equatorial intensity ratio I11/I10, and no
change in the rate constant of force redevelopment (6).
Therefore, in the skeletal fiber, caldesmon clearly causes
cross-bridge detachment, and there is no indication of reg-
ulation of a transition between two attached states. In our
present results, from experiments done in the absence of tro-
pomyosin, we observe slightly more inhibition of ATPase
activity than expected from the amount of bound caldesmon
(Fig. 4, open symbols). Since this effect is small, it is difficult
to rule out errors in measuring caldesmon binding. It is also
possible that while the 20 kDa fragment binds tightly to two
actin monomers, it could inhibit the binding of S-1 ATP to
adjacent sites. Thus, in Fig. 5, there is a strong correlation
between the inhibition of ATPase activity and inhibition of
S-1 ATP binding to actin.
While there is now agreement that caldesmon competes
with myosin binding, there is an active debate over the im-
portance of this inhibition of binding in the presence of tro-
pomyosin (38, 39). It is clear from our past (19, 28, 33) and
present work that caldesmon is a more effective inhibitor of
ATPase activity in the presence of tropomyosin. Fig. 4 shows
that the rate of ATPase activity is enhanced by tropomyosin
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and that this rapid ATPase activity is strongly inhibited by
caldesmon. One-third as much bound caldesmon is required
for 50% inhibition as in the absence of tropomyosin. There
is cooperativity in the inhibition of ATPase activity that is
seen only in the presence of tropomyosin. However, while
caldesmon inhibits the cooperative activation of ATPase ac-
tivity by smooth tropomyosin (12) there is considerable ev-
idence that competition of binding remains a dominant fea-
ture in regulation (6, 11, 13, 14, 17, 21, 37). For example, we
have observed that the ability of caldesmon to compete with
S-1 binding is enhanced by tropomyosin (17). It is particu-
larly noteworthy, as already discussed, that the 20 kDa frag-
ments inhibit cross-bridge binding in skinned striated muscle
fibers (6). This fiber preparation contains tropomyosin, albeit
skeletal muscle tropomyosin, and in addition maintains the
geometry and relative abundance of proteins expected in a
physiological system.
The results of our studies suggest that the stoichiometry of
binding of caldesmon fragments to actin is related to the size
of the caldesmon fragment. This implies that different re-
gions of caldesmon are binding to different actin monomers
(see Ref. 17). Thus, in our hands, intact caldesmon binds to
about seven actin monomers (28), the 20 kDa fragment binds
to about two actin monomers (present study), and the 7.3 kDa
fragment, which is the NH2 terminal region of the 20 kDa
fragment, binds to one actin monomer (19). We would have
predicted, from these results, that the COOH-terminal half of
the 20 kDa fragment would also bind to a single actin mono-
mer. However, a CNBr fragment of caldesmon, which is es-
sentially the COOH-terminal region of the 20 kDa fragment,
is reported to bind to actin with a 1:7 stoichiometry (40),
much like intact caldesmon. We cannot explain this result at
present.
Caldesmon has been shown earlier to bind to tropomyosin
(32), and this has been localized to the 38 kDa COOH-
terminal region (41). We have observed that fragments from
both the NH2- and COOH-terminal regions of caldesmon
bind to tropomyosin, although it is not clear if these are both
physiologically significant interactions. Likely regions for
the tropomyosin-binding sites are the two tropomyosin-
binding consensus sequences at residues 508-565 and 592-
623 (42-44). Our 20 kDa fragments contain this second re-
gion. Watson et al. (45) have suggested that residues 142-227
of tropomyosin are involved in the binding of intact caldes-
mon but the site to which this region of tropomyosin binds
has not been identified. Although the 20 kda caldesmon frag-
ments bind to tropomyosin, there is little effect of tropomy-
osin on the binding of caldesmon to actin. This is not totally
unexpected since earlier studies have shown that tropomy-
osin has a relatively small (about threefold) effect on the
binding of intact caldesmon to actin (28), even though
caldesmon binds as tightly to tropomyosin in solution (46)
as caldesmon binds to actin (28). These results indicate that
the caldesmon-binding site on tropomyosin may be partially
inaccessible in the presence of actin.
In conclusion, the 20 kDa actin-binding fragments of
caldesmon have the inhibitory properties normally associ-
ated with caldesmon but lack the complication of binding to
myosin. These fragments are well suited for perturbing the
"weak" binding of myosin to actin that occurs during ATP
hydrolysis both in solution and in muscle.
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